Journal of Clinical Endocrinology & Metabolism, Vol 61, 769-772, Copyright © 1985 by Endocrine Society

ARTICLES

Comparison of iodobenzylguanidine imaging with computed tomography in locating pheochromocytoma

JF Chatal and B Charbonnel

Ninety-nine patients suspected of having pheochromocytoma were studied with [131I]metaiodobenzylguanidine scintigraphy, and 92 of them were studied with computed tomography (CT). In 49 patients, the diagnosis was ruled out; in 3 patients, it remained doubtful; and in 47 patients, it was confirmed. Two patients had tumors that did not secrete epinephrine or norepinephrine, and 45 had secreting pheochromocytomas. In these latter patients, there were 4 false negative [131I]metaiodobenzylguanidine scans, all intraadrenal tumors, and 4 false negative CT scans, 3 extraadrenal and 1 intraadrenal tumors. For about 80% of the patients and/or the tumor sites, both methods were thus in agreement. They were complementary in the remaining 20%. The advantage of scintigraphy is to screen the whole body with high specificity and to locate extra-adrenal sites or metastases of pheochromocytoma with better accuracy than CT. The limits of scintigraphy are the possibility of false negative scans in around 10% of patients, whereas CT visualizes more than 95% of intraadrenal tumors.

This article has been cited by other articles:

				M. Baghai, G. B. Thompson, W. F. Young Jr, C. S. Grant, V. V. Michels, and J. A. van Heerden Pheochromocytomas and Paragangliomas in von Hippel-Lindau Disease: A Role for Laparoscopic and Cortical-Sparing Surgery Arch Surg, June 1, 2002; 137(6): 682 - 689. [Abstract] [Full Text] [PDF]

				Y Inoue, M Akahane, T Kitazawa, H Ijichi, S Obi, K Yoshikawa, K Ohtomo, and M Omata False positive uptake of metaiodobenzylguanidine in hepatocellular carcinoma Br. J. Radiol., June 1, 2002; 75(894): 548 - 551. [Abstract] [Full Text] [PDF]

				G. A. Yanik, J. E. Levine, K. K. Matthay, J. C. Sisson, B. L. Shulkin, B. Shapiro, D. Hubers, S. Spalding, T. Braun, J. L.M. Ferrara, et al. Pilot Study of Iodine-131-Metaiodobenzylguanidine in Combination With Myeloablative Chemotherapy and Autologous Stem-Cell Support for the Treatment of Neuroblastoma J. Clin. Oncol., April 15, 2002; 20(8): 2142 - 2149. [Abstract] [Full Text] [PDF]

				S. K. Nagesser, J. Kievit, J. Hermans, H. M. J. Krans, and C. J.H. van de Velde The Surgical Approach to the Adrenal Gland: a Comparison of the Retroperitoneal and the Transabdominal Routes in 326 Operations on 284 Patients Jpn. J. Clin. Oncol., February 1, 2000; 30(2): 68 - 74. [Abstract] [Full Text] [PDF]

				T. Rainis, S. Ben-Haim, and G. Dickstein False Positive Metaiodobenzylguanidine Scan in a Patient with a Huge Adrenocortical Carcinoma J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 5 - 7. [Abstract] [Full Text]

				B. L. Shulkin, N. W. Thompson, B. Shapiro, I. R. Francis, and J. C. Sisson Pheochromocytomas: Imaging with 2-[Fluorine-18]fluoro-2-deoxy-D-glucose PET Radiology, July 1, 1999; 212(1): 35 - 41. [Abstract] [Full Text]

				S. Sandur, A. Dasgupta, J. L. Shapiro, A. C. Arroliga, and A. C. Mehta Thoracic Involvement With Pheochromocytoma: A Review Chest, February 1, 1999; 115(2): 511 - 521. [Abstract] [Full Text] [PDF]

				H. Neumann, D. P. Berger, G. Sigmund, U. Blum, D. Schmidt, R. J. Parmer, B. Volk, and G. Kirste Pheochromocytomas, Multiple Endocrine Neoplasia Type 2, and von Hippel-Lindau Disease N. Engl. J. Med., November 18, 1993; 329(21): 1531 - 1538. [Abstract] [Full Text]